Skip to content

Clinical trials

Diabetes Mellitus, Type 2 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Country / region: United States Clear all

3,219 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200019
200126
200233
200345
200478
200584
2006113
2007130
2008167
2009199
2010167
2011150
2012142
2013140
2014142
2015113
2016100
2017131
2018121
2019121
202094
2021167
2022146
2023141
2024141
2025137
2026134

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2,351
Recruiting247
Terminated243
Active, not recruiting125
Unknown status99
Withdrawn82
Enrolling by invitation35
Not yet recruiting27
Suspended9
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S175
AstraZeneca167
Eli Lilly and Company139
GlaxoSmithKline78
Sanofi64
Pfizer62
Boehringer Ingelheim52
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)52
Hoffmann-La Roche42
University of Colorado, Denver41

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 23,219
Diabetes Mellitus736
Obesity388
Insulin Resistance195
Diabetes Mellitus, Type 1179
Hypertension121
Overweight115
Cardiovascular Diseases104
Prediabetic State89
Glucose Intolerance72

Trials

Showing 51 to 75 of 3,219. Each trial links to its page on Pharma Observatory.

3,119 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.